NCT04049006 is a NA clinical trial of complex treatment in Fibromyalgia, sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina.

Who is sponsoring NCT04049006?

NCT04049006 is sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina.

What drugs are being tested in NCT04049006?

Interventions in NCT04049006: complex treatment.

What condition does NCT04049006 study?

NCT04049006 studies Fibromyalgia.

Is NCT04049006 still recruiting?

NCT04049006 is currently completed. Last updated 7 September 2023.

Last reviewed 2023-09-07 · How we verify

NCT04049006

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness and Cost-utility of a Complex Intervention for Fibromyalgia Patients

Completed NA Last updated 7 September 2023

What this trial tests

NA trial testing complex treatment in Fibromyalgia in 302 participants. Completed in 31 March 2021.

Timeline

1 April 2019

Primary endpoint
31 March 2021

31 March 2021

Quick facts

Lead sponsor	Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	302
Start date	1 April 2019
Primary completion	31 March 2021
Estimated completion	31 March 2021
Sites	1 location across Spain

Drugs / interventions tested

complex treatment

Conditions studied

Fibromyalgia — all drugs for Fibromyalgia →

Sponsor

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina — full company profile →

Who can join

Eligibility, any sex, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Fibromyalgia (FM) is a chronic disease characterized by chronic pain, fatigue and loss of function that leads to a significant deterioration in the quality of life. Despite controversies about the most appropriate treatment, studies indicate that a multidisciplinary treatment would be effective. This study aims to analyze the effectiveness and cost-utility of a complex intervention in the quality of life (main variable), the functional impact, the mood and the pain of people with FM treated in the Primary Care Teams (PCTs) of the Catalan Institute of Health (CIH).

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

Effectiveness, cost-utility, and benefits of a multicomponent therapy to improve the quality of life of patients with fibromyalgia in primary care: A mixed methods study protocol.
Caballol Angelats R, Gonçalves AQ, Aguilar Martín C, Sancho Sol MC, et al · · 2019 · cited 15× · PMID 31593081 · DOI 10.1097/md.0000000000017289
Patients' Lived Experience in a Multicomponent Intervention for Fibromyalgia Syndrome in Primary Care: A Qualitative Interview Study.
Arfuch VM, Caballol Angelats R, Aguilar Martín C, Gonçalves AQ, et al · · 2022 · cited 10× · PMID 36293900 · DOI 10.3390/ijerph192013322
Patients' appraisals about a multicomponent intervention for fibromyalgia syndrome in primary care: a focus group study.
Arfuch VM, Queiroga Gonçalves A, Caballol Angelats R, Aguilar Martín C, et al · · 2021 · cited 8× · PMID 34839810 · DOI 10.1080/17482631.2021.2005760
Effectiveness of a Multicomponent Program for Fibromyalgia Patients in a Primary Care Setting (FIBROCARE Program): A Pragmatic Randomized Controlled Trial.
Caballol Angelats R, Gonçalves AQ, Abellana R, Carrasco-Querol N, et al · · 2024 · cited 4× · PMID 39797245 · DOI 10.3390/jcm14010161
Cost-utility of a multicomponent intervention for fibromyalgia versus usual care: a pragmatic randomised controlled trial.
Arfuch VM, Aguilar Martín C, Berenguera A, Caballol Angelats R, et al · · 2023 · cited 4× · PMID 38111994 · DOI 10.2340/jrm.v55.12361
Assessing the benefits on quality of life of a multicomponent intervention for fibromyalgia syndrome in primary care: patients' and health professionals' appraisals: a qualitative study protocol.
Arfuch VM, Caballol Angelats R, Aguilar Martín C, Carrasco-Querol N, et al · · 2020 · cited 4× · PMID 33177139 · DOI 10.1136/bmjopen-2020-039873
Cost-utility analysis of a multicomponent intervention for fibromyalgia syndrome in primary care versus usual clinical practice: study protocol for an economic evaluation of a randomised control trial.
Arfuch VM, Aguilar Martín C, Berenguera A, Caballol Angelats R, et al · · 2021 · cited 3× · PMID 33550259 · DOI 10.1136/bmjopen-2020-043562
Usefulness of a Multicomponent Group Intervention Program for Fibromyalgia Patients in Primary Care: A Qualitative Study of Health Professionals.
Caballol Angelats R, Aguilar Martín C, Carrasco-Querol N, Abellana R, et al · · 2023 · cited 1× · PMID 38200923 · DOI 10.3390/healthcare12010017

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
NCT07245303 — Neural Mechanisms of Light Driven Analgesia · NA · recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
NCT07465991 — The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia · NA · recruiting

Other Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina trials

Trials by the same sponsor.

NCT07441759 — throMboembolic Risk Associated To High atrIal Fibrillation riSk · not yet recruiting
NCT07132632 — Effect of a Multicomponent Therapeutic Exercise Program in Primary Care on Frailty and Sarcopenia in Older Adults · NA · not yet recruiting
NCT07373119 — Improving Frailty in Patients With Stable Ischemic Heart Disease · NA · enrolling by invitation
NCT06581367 — Tailoring Antibiotic Duration for Respiratory Tract Infections in Primary Care · Phase 4 · not yet recruiting
NCT06988904 — ENERGY2MOB STUDY: OBESITY MANAGEMENT IN BERGUEDÀ · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04049006 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Last refreshed: 7 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04049006.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing